Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 116,287 |
|
|||||
| News | - | ||||||
| Day High | 220.00 | Low High |
|||||
| Day Low | 209.62 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Madrigal Pharmaceuticals Inc | MDGL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -8.48 | -3.88% | 209.90 | 12:15:35 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 218.08 | 209.62 | 220.00 | 218.38 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,132 | 116,287 | $ 214.51 | $ 24,944,199 | - | 119.7604 - 322.67 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:15:49 | 29 | $ 210.125 | USD |
Madrigal Pharmaceuticals (MDGL) Options Flow Summary
Madrigal Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.27B | 19.90M | - | 0 | -373.63M | -18.78 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Madrigal Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MDGL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 235.91 | 235.91 | 197.43 | 216.64 | 456,272 | -26.01 | -11.03% |
| 1 Month | 250.00 | 268.22 | 197.43 | 237.61 | 386,712 | -40.10 | -16.04% |
| 3 Months | 222.44 | 299.98 | 168.2462 | 235.92 | 607,381 | -12.54 | -5.64% |
| 6 Months | 128.09 | 299.98 | 119.7604 | 219.28 | 481,716 | 81.81 | 63.87% |
| 1 Year | 303.50 | 322.67 | 119.7604 | 214.08 | 427,720 | -93.60 | -30.84% |
| 3 Years | 130.28 | 322.67 | 52.33 | 179.02 | 316,527 | 79.62 | 61.11% |
| 5 Years | 109.37 | 322.67 | 52.33 | 158.56 | 256,669 | 100.53 | 91.92% |
Madrigal Pharmaceuticals Description
| Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. |
